These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18352844)

  • 1. Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy.
    Elkord E; Hawkins RE; Stern PL
    Expert Opin Biol Ther; 2008 Apr; 8(4):385-95. PubMed ID: 18352844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Therapy in GI Malignancies: A Review.
    Wang J; Reiss KA; Khatri R; Jaffee E; Laheru D
    J Clin Oncol; 2015 Jun; 33(16):1745-53. PubMed ID: 25918295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy for gastrointestinal malignancies.
    Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
    Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
    Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
    World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccination in patients with gastrointestinal malignancies. A review of immunological and clinical results.
    Mosolits S; Ullenhag G; Mellstedt H
    Ann Oncol; 2005 Jun; 16(6):847-62. PubMed ID: 15829493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    J Drug Target; 2013 Feb; 21(2):126-36. PubMed ID: 23061479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine and antibody-directed T cell tumour immunotherapy.
    Dermime S; Gilham DE; Shaw DM; Davidson EJ; Meziane el-K; Armstrong A; Hawkins RE; Stern PL
    Biochim Biophys Acta; 2004 Jul; 1704(1):11-35. PubMed ID: 15238242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.
    Amedei A; Niccolai E; D'Elios MM
    Clin Dev Immunol; 2011; 2011():320571. PubMed ID: 22110523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and biological therapies of gastrointestinal tumors: overview of clinical trials.
    Morse MA; Lyerly HK
    Ann Surg Oncol; 1999 Mar; 6(2):218-23. PubMed ID: 10082049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint modulation: rational design of combination strategies.
    Zamarin D; Postow MA
    Pharmacol Ther; 2015 Jun; 150():23-32. PubMed ID: 25583297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects.
    Zhou C; Zhang J
    Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
    Amedei A; Niccolai E; Prisco D
    Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
    Wang DK; Zuo Q; He QY; Li B
    Front Immunol; 2021; 12():705999. PubMed ID: 34447376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
    Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
    J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral immunotherapy: using the tumor as the remedy.
    Marabelle A; Tselikas L; de Baere T; Houot R
    Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy: moving forward with peptide T cell vaccines.
    Kumai T; Fan A; Harabuchi Y; Celis E
    Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The present status and future prospects of peptide-based cancer vaccines.
    Hirayama M; Nishimura Y
    Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
    Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.